"Pegylated Interferon alpha emerges as a possibility to treat COVID-19"- Dr Sharvil Patel
22 April 2020 | Views
Dr Sharvil Patel, Managing Director, Cadila Healthcare, Ahmedabad talks about the initiatives the company is taking to tackle COVID-19
"At this juncture, as the healthcare fraternity the world over, is exploring options for a safe and efficacious treatment to combat COVID 19, Pegylated Interferon alpha emerges as one such possibility with it’s potential to reduce virus titres when given earlier in the disease and offering better clinical outcomes. We are working with the U.S. Food and Drug Administration (FDA) and have opened an investigational new drug (IND) filing for Pegylated Interferon alpha-2b for the treatment of COVID-19. We are also working with the Department of Biotechnology to investigate the role of Pegylated Interferon alpha-2b for COVID 19 and are planning to undertake clinical trials for this.”
- Dr Sharvil Patel, Managing Director, Cadila Healthcare, Ahmedabad
